About Us

•   A technology executive with over 30 years of experience driving innovation in analytics, artificial intelligence, and data strategy 

•   Recognized for leading high-impact digital transformations, building world-class teams, and delivering cutting-edge solutions across global enterprises 

•    Passionate about harnessing data to unlock business value, with a proven track record of scaling emerging technologies and shaping forward-thinking strategies in dynamic, fast-paced environments 

    •    Leads manufacturing strategy and oversees development of diagnostic products from concept to commercialization.

    •    Brings 17+ years of biotechnology experience across R&D, Manufacturing, and Quality Control.

    •    6+ years in management within regulation under Australia, Canada, EU and US, and ISO 13485 and MDSAP compliant facilities.

    •    Former leader at Abcam, where she managed manufacturing operations, directed cross-functional teams, and supported multiple product launches.

    •    Named inventor on a U.S. patent for devices, systems, and methods for processing magnetic particles.

    •    Co-author of scientific posters and publications in molecular diagnostics.

    •    Holds a B.S. in Biochemistry & Molecular Biology from UC Davis and a Certification in Clinical Trial Design & Management from UC Santa Cruz.

    •    Passionate about advancing innovative diagnostic solutions and building collaborative, high-performing teams.•   Dr. Harb previously founded Horizon Oncology and Research Center, which grew into Verdi Oncology, a national oncology management company focused on value-based care and innovative therapies. He has also held leadership roles at Indiana University Health and Hoosier Cancer Research Network, shaping clinical research programs and expanding patient access to cutting-edge treatments.

•   Dr. Harb earned his medical degree from the University of Damascus, completed fellowship training in oncology at Indiana University, and holds an Executive MBA from the University of California, Irvine

•   B.S. Computer Science from University of California, Santa Cruz

•  Solutions engineer with experience bridging technical solutions and business strategy

•.  International experience translating technical requirements into customer success stories 

•.  Hands-on experience in software development and product management in reseller and white label solutions

•   Proven track record in API/SDK platform development, specifically in routing and navigation 

•.  Committed to empowering people with modern, scalable AI software solutions

•   An innovator and expert in stem cell biology, regenerative medicine, and biochemical engineering. 

•   Research contributed to major advances in cellular reprogramming and induced pluripotency. 

•   Co-founded companies at the interface of science, medicine, and aesthetics. 

•   Co-founder of Xytogen Biotech and ELEVAI Labs Inc., two pioneering companies in the cosmeceutical and regenerative skincare space. 

•   Led the development of a portfolio of exosome-based skin and haircare products that brought advanced stem cell science to medical aesthetics. 

•   Developed and launched more than 20 products, translating cutting-edge stem cell research, regenerative medicine, genomics, and longevity science into commercially successful innovations. 

•   Published his research in respected journals such as Nature Methods, the Journal of Cellular and Molecular Medicine, and Stem Cell Research & Therapy.

•   Invented iSWAB for swab-based collection, and HemaSure-OMICs, a direct draw-tube for whole blood multi-omics analysis.

•   Founder and CTO of Mawi DNA Technologies, a growth-stage company working at the front lines of the COVID-19 battle. 

•   More than 25 years of experience in the genomics sample preparation market. 

•   Led nucleic acid purification technologies commercialization at both Beckman Coulter Genomics (formerly Agencourt) and Corning. 

•   Published several patents for simplifying nucleic acid purification and sample collection. 

•   Dr. Wael Harb is Vice President of Medical Management at Syneos Health, where he provides medical leadership for global early-phase oncology and hematology trials. A board-certified oncologist with more than 20 years of clinical and research experience, he has served as principal investigator on over 100 clinical trials, advancing targeted therapies, immuno-oncology, antibody-drug conjugates, and novel therapeutics.

•   Dr. Harb previously founded Horizon Oncology and Research Center, which grew into Verdi Oncology, a national oncology management company focused on value-based care and innovative therapies. He has also held leadership roles at Indiana University Health and Hoosier Cancer Research Network, shaping clinical research programs and expanding patient access to cutting-edge treatments.

•   Dr. Harb earned his medical degree from the University of Damascus, completed fellowship training in oncology at Indiana University, and holds an Executive MBA from the University of California, Irvine